Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: A randomized controlled trial

Glucose-insulin-potassium therapy improves early postoperative cardiovascular performance, reduces inotrope requirement, and might reduce myocardial injury. These potential benefits are not at the expense of increased noncardiac morbidity.